Chen, Kai
Gao, Yanyan
Xia, Ninuo
Liu, Yusheng
Wang, Huiru
Ma, Hui
Zheng, Shengxia
Fang, Fang https://orcid.org/0000-0002-5272-302X
Funding for this research was provided by:
National Natural Science Foundation of China (32070830, 81971339)
National Key Research and Development Program of China (2022YFA0806301 to F.F.)
Article History
Received: 19 July 2024
Accepted: 7 December 2024
First Online: 23 December 2024
Declarations
:
: H-eMSC were obtained from the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, AnHui, China. Collection of the H-eMSC was approved by the Institutional Animal Care and Use Committee at the First Affiliated Hospital of USTC (code no. 2023KY300, Title: Therapeutic effects of mesenchymal stem cell for intrauterine adhesion. Date of approval: 14 Sep 2023), and all the patients signed informed consent before participating in the study. All animal experiments were conducted in accordance with the Guide for the Care and Use of Animals for Research Purposes. All the procedures were approved by the Institutional Animal Care and Use Committee at the First Affiliated Hospital of USTC (code no. 2022-N(A)-119, Title: Regulatory network of Wnt/β-catenin signaling pathway in menstrual blood stem cells repairing thin endometrial fertility. Date of approval: 9 May 2023).
: All authors gave consent for publication.
: The authors declare that they have no competing interests.